Emerging perspectives in proteostasis: bridging mechanisms and therapeutics for human diseases
Ankush Borlepawar, Marco Neu, Ziqi Ma, Anushka Deshpande, Hannah Bühringer, Parvana Hajieva, Norbert Frey, Ashraf Yusuf Rangrez · 2026
Read Emerging perspectives in proteostasis: bridging mechanisms and therapeutics for human diseases by Ankush Borlepawar, Marco Neu, Ziqi Ma, Anushka Deshpande, Hannah Bühringer, Parvana Hajieva, Norbert Frey, Ashraf Yusuf Rangrez (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-13246805.txt.
Description
Borlepawar, Neu, Ma, and co-authors review proteostasis, the cell's system for keeping its proteins correctly made, folded, moved, and destroyed, in this 2026 Signal Transduction and Targeted Therapy article. Chaperone proteins, the proteasome shredder, autophagy, and organelle quality-control programs all cooperate in that balance. When it collapses, misshapen proteins pile up and drive disease.
The authors link proteostasis failure across Alzheimer's-type neurodegeneration, cancer, heart and metabolic disease, and autoimmunity, hitting hardest in heart and brain tissue that barely regenerates. They frame the system's strength as proteostasis resilience, its capacity to absorb stress and restore balance. The review closes with emerging drug platforms that aim to restore that resilience rather than fix single broken parts.
Catalog record
| CREATOR | Ankush Borlepawar, Marco Neu, Ziqi Ma, Anushka Deshpande, Hannah Bühringer, Parvana Hajieva, Norbert Frey, Ashraf Yusuf Rangrez |
|---|---|
| YEAR | 2026 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 244 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |